Results 61 to 70 of about 759,290 (286)

Legibility of prescription medication labelling [PDF]

open access: yesCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2014
I continue to appreciate the updated look of the CPJ and the consistent high quality and applicability of the articles. The Original Research contribution1 on the legibility of prescription medication labelling in Canada came at a convenient time for me.
openaire   +2 more sources

Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) risk differs by sex and age, implicating sex hormones as potential modifiers. This study examined plasma levels of biologically active sex hormones and their association with ALS odds and survival in cases (females n = 131, males n = 189) and controls (females n = 138, males n = 150) from the University of ...
Stephen A. Goutman   +5 more
wiley   +1 more source

Mind Your Meds: Safe Opioid Disposal Awareness [PDF]

open access: yes, 2019
Driven by the effects of the opioid epidemic on friends, family members, students, and patients, members of the 2019 GEHLI Team “Mission Possible” are dedicated to bolstering educational awareness of safe leftover opioid disposal methods to decrease the ...
at Virginia Commonwealth University, The Grace E. Harris Leadership Institute   +7 more
core   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4

open access: yesZeitschrift für Kristallographie - New Crystal Structures
C19H17FINO4, triclinic, P1̄ (no. 2), a = 7.1158(2) Å, b = 11.1914(3) Å, c = 12.4974(3) Å, α = 73.015(2)°, β = 87.945(2)°, γ = 78.137(2)°, V = 931.19(4) Å3, Z = 2, R gt(F) = 0.0563, wRref (F 2) = 0.1639, T = 293(2) K.
Yuan Jia-Cheng   +4 more
doaj   +1 more source

Bioinspired porous core-shell microspheres with spatiotemporal delivery coordinate immunomodulatory-osteogenic coupling via NF-κB/P-STAT6 and Rho/MAPK signaling for enhanced calvarial regeneration

open access: yesBioactive Materials
Critical-sized calvarial defects remain a formidable clinical challenge due to dyssynchronous immunomodulation-osteogenesis coupling and unregulated growth factor release.
Jiahe Zheng   +8 more
doaj   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

open access: yesArthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah   +5 more
wiley   +1 more source

Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl) (2-iodo-5-methoxyphenyl)methanone, C20H20INO5

open access: yesZeitschrift für Kristallographie - New Crystal Structures
C20H20INO5, monoclinic, P21/c (no. 14), a = 14.49960(10) Å, b = 18.5114(2) Å, c = 7.09190(10) Å, β = 95.2400(10)°, V = 1895.57(4) Å3, Z = 4, Rgt(F) = 0.0348, wRref(F2) = 0.0913, T = 293(2) K.
Yuan Jia-Cheng   +4 more
doaj   +1 more source

Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care [PDF]

open access: yes
This study tests the impact of a public prescription benefit on Medicare-eligible veterans, utilizing a mid-1990s benefit change in the VA health care system.
Melissa Boyle
core  

Home - About - Disclaimer - Privacy